Analysis of targeted somatic mutations in pleomorphic carcinoma of the lung usingnext-generationsequencing technique
Analysis of targeted somatic mutations in pleomorphic carcinoma of the lung usingnext-generationsequencing technique
复制标题
DOI:
10.1111/1759-7714.13536
复制
发表时间:
2020-06-23
期刊:
影响因子:
2.9
通讯作者:
Yamada, Kouzo
中科院分区:
文献类型:
--
作者:
Manabe, Saki;Kasajima, Rika;Yamada, Kouzo
Background Pleomorphic carcinoma (PC) of the lung is a rare type of lung cancer with aggressive characteristics and a poor prognosis. Because it is rare, the molecular characteristics of PC remain unclear. Methods A gene mutation analysis was performed using next-generation sequencing (NGS) in patients with PC of the lung who had undergone surgical resection. Results A total of nine patients were enrolled in the study. All the patients were male and eight had a history of smoking. Eight tumors contained spindle cells and three contained giant cells. Mutations considered significant were found in eight of the nine patients: inTP53in five patients, inMETin two patients, and inALK,ERBB2,PIK3CA,APC,NF1, andCDKN2Ain one patient each. NoEGFRmutation was detected in our analysis. Co-mutations were detected in three patients:TP53withMETandNF1,TP53 with ERBB2, andPIK3CAwithCDKN2A. Conclusions TP53mutations were detected most frequently in PC of the lung with NGS analysis. Different co-mutations were seen in several specimens. Key pointsSignificant findings of the study This study demonstrates that mutations in the TP53 gene are frequently found and co-mutations are sometimes found in pleomorphic carcinoma of the lung using genomic profiling analysis. What this study adds Our results will help to analogize the genetic characteristics and potential target of molecular-targeted agents of pleomorphic carcinoma of the lung.